Biolife Solutions Announces Preliminary Unaudited Revenue Results for Fourth Quarter and Full Year 2023
For the year, the company reported revenue for the full year 2023 was $143.3 million, a decrease of 11% from $161.8 million for 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.53 USD | +3.97% | +10.53% | +7.88% |
1st Jan change | Capi. | |
---|---|---|
+7.88% | 794M | |
-2.31% | 187B | |
-3.20% | 106B | |
-5.04% | 66.9B | |
+0.20% | 49.45B | |
+17.29% | 48B | |
+4.06% | 40.84B | |
+2.07% | 26.48B | |
+2.36% | 26.25B | |
+12.96% | 24.62B |